Eli Lilly and Company (LLY) Valuation Metrics

Price to Earnings

CAGRVariation 10 years

PER

+ 4.69 %

+ 58.1 %

Price to Sales

CAGRVariation 10 years

Price to Sales

+ 14.52 %

+ 288.08 %

Price to Book

CAGRVariation 10 years

Price to Book

+ 20.19 %

+ 529.19 %

Price to Earnings Growth

CAGRVariation 10 years

PEG

- 13.47 %

- 76.48 %

Price to Free Cash Flow

CAGRVariation 10 years

Price to Free Cash Flow

+ 17.45 %

+ 399.37 %

Enterprise Value

CAGRVariation 10 years

EV / Revenue

+ 14.15 %

+ 275.73 %

EV / EBITDA

+ 7.64 %

+ 108.84 %

EV / Free Cash Flow

+ 17.07 %

+ 383.48 %

Eli Lilly and Company

LLY - US5324571083

$ 878,24

Eli Lilly and Company

LLY - US5324571083

$ 878,24

Invvest valuation chart ™

Unlock this feature

Customization

Price to Earnings

Price to Sales

Price to Book

Price to Earnings Growth

Price to Free Cash Flow

Enterprise Value

Image Modal

Eli Lilly and Company

LLY - US5324571083

$ 878,24

Image Modal

Eli Lilly and Company

LLY - US5324571083

$ 878,24

Invvest valuation chart ™

Unlock this feature

Customization

Price to Earnings

Price to Sales

Price to Book

Price to Earnings Growth

Price to Free Cash Flow

Enterprise Value